A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
Open Access
- 3 August 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (8) , 1241
Abstract
Duchenne muscular dystrophy (DMD) is a severe X-linked muscle wasting disease with no cure. While the precise mechanisms of progressive dystropathology remain unclear, oxidative stress caused by excessive generation of oxidants is strongly implicated. Blood biomarkers that could track oxidant levels in tissues would be valuable to measure the effectiveness of clinical treatments for DMD; our research has focused on developing such biomarkers. One target of oxidants that has the potential to be harnessed as a clinical biomarker is the thiol side chain of cysteine 34 (Cys34) of the blood protein albumin. This study using the mdx mouse model of DMD shows that in plasma, albumin Cys34 undergoes thiol oxidation and these changes correlate with levels of protein thiol oxidation and damage of the dystrophic muscles. A comparison with the commonly used biomarker protein carbonylation, confirmed that albumin thiol oxidation is the more sensitive plasma biomarker of oxidative stress occurring in muscle tissue. We show that plasma albumin oxidation reflects muscle dystropathology, as increased after exercise and decreased after taurine treatment of mdx mice. These data support the use of albumin thiol oxidation as a blood biomarker of dystropathology to assist with advancing clinical development of therapies for DMD.Keywords
Funding Information
- Duchenne Research Fund (N/A)
- Save Our Sons (N/A)
- AFM-Téléthon (21186)
- Higher Committee for Education Development in Iraq (N/A)
This publication has 87 references indexed in Scilit:
- Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx miceThe International Journal of Biochemistry & Cell Biology, 2013
- Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathiesThe FEBS Journal, 2013
- Human serum albumin: From bench to bedsideMolecular Aspects of Medicine, 2012
- Isoprostane Generation and FunctionChemical Reviews, 2011
- A fluorescent dual labeling technique for the quantitative measurement of reduced and oxidized protein thiols in tissue samplesFree Radical Biology and Medicine, 2011
- Blood reflects tissue oxidative stress depending on biomarker and tissue studiedFree Radical Biology and Medicine, 2009
- Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading testAmino Acids, 2009
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: Biochemical and immunological studiesLife Sciences, 2006
- Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassayFree Radical Biology and Medicine, 1994